Viewing StudyNCT00346099



Ignite Creation Date: 2024-05-05 @ 4:55 PM
Last Modification Date: 2024-10-26 @ 9:26 AM
Study NCT ID: NCT00346099
Status: WITHDRAWN
Last Update Posted: 2008-01-07
First Post: 2006-06-27

Brief Title: Study of Panitumumab Given First With Capecitabine and Oxaliplatin CAPOX and Then With Capecitabine and Radiation of the Pelvis for Treatment of Patients With Rectal Cancers That May or May Not Have Spread Beyond the Rectum
Sponsor: NSABP Foundation Inc
Organization: NSABP Foundation Inc

Organization Data

Organization: NSABP Foundation Inc
Class: NETWORK
Study ID: NSABP FR-1
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: NSABP Foundation Inc
Lead Sponsor Class: NETWORK
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: Norman Wolmark MD
Old Organization: NSABP Foundation Inc

Collaborators

Name Class
Amgen INDUSTRY